[Potentiation of human insulin secretion due to tolbutamide after treatment with dihydroergocristine (DHC)]. 1977

S Bertolini, and C Castello, and G E Jacopino, and G Barban, and A Fattorini, and G L Schiaffino, and R Balestreri

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D004088 Dihydroergotoxine A mixture of three different hydrogenated derivatives of ERGOTAMINE: DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and DIHYDROERGOCRYPTINE. Dihydroergotoxine has been proposed to be a neuroprotective agent and a nootropic agent. The mechanism of its therapeutic actions is not clear, but it can act as an alpha-adrenergic antagonist and a dopamine agonist. The methanesulfonate salts of this mixture of alkaloids are called ERGOLOID MESYLATES. Co-Dergocrine,Ergot Alkaloids, Hydrogenated,Dihydroergotoxin,Alkaloids, Hydrogenated Ergot,Hydrogenated Ergot Alkaloids
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D014044 Tolbutamide A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) Apo-Tolbutamide,Artosin,Diabetol,Diaval,Dolipol,Orabet,Orinase,Rastinon,Tolbutamid R.A.N.

Related Publications

S Bertolini, and C Castello, and G E Jacopino, and G Barban, and A Fattorini, and G L Schiaffino, and R Balestreri
October 1979, Experientia,
S Bertolini, and C Castello, and G E Jacopino, and G Barban, and A Fattorini, and G L Schiaffino, and R Balestreri
May 1980, Diabetes,
S Bertolini, and C Castello, and G E Jacopino, and G Barban, and A Fattorini, and G L Schiaffino, and R Balestreri
November 1972, Acta medica Scandinavica,
S Bertolini, and C Castello, and G E Jacopino, and G Barban, and A Fattorini, and G L Schiaffino, and R Balestreri
November 1964, Metabolism: clinical and experimental,
S Bertolini, and C Castello, and G E Jacopino, and G Barban, and A Fattorini, and G L Schiaffino, and R Balestreri
September 1978, Diabetologia,
S Bertolini, and C Castello, and G E Jacopino, and G Barban, and A Fattorini, and G L Schiaffino, and R Balestreri
December 1972, Endocrinology,
S Bertolini, and C Castello, and G E Jacopino, and G Barban, and A Fattorini, and G L Schiaffino, and R Balestreri
November 1960, Deutsche medizinische Wochenschrift (1946),
S Bertolini, and C Castello, and G E Jacopino, and G Barban, and A Fattorini, and G L Schiaffino, and R Balestreri
January 1969, German medical monthly,
S Bertolini, and C Castello, and G E Jacopino, and G Barban, and A Fattorini, and G L Schiaffino, and R Balestreri
March 1974, L'union medicale du Canada,
S Bertolini, and C Castello, and G E Jacopino, and G Barban, and A Fattorini, and G L Schiaffino, and R Balestreri
November 1957, The Journal of clinical investigation,
Copied contents to your clipboard!